0001209191-21-045049.txt : 20210702 0001209191-21-045049.hdr.sgml : 20210702 20210702170116 ACCESSION NUMBER: 0001209191-21-045049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210702 DATE AS OF CHANGE: 20210702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HALE DAVID F CENTRAL INDEX KEY: 0001024004 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 211071139 MAIL ADDRESS: STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430 CITY: ENCINITAS STATE: CA ZIP: 92024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-30 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001024004 HALE DAVID F 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2021-06-30 4 S 0 3669 4.75 D 713152 I By Hale BioPharma Ventures, LLC Common Stock 18346 I By Hale Trading Company These shares were transferred to Oxford Finance LLC by Hale BioPharma Ventures, LLC in satisfaction of a pledge by Hale BioPharma Ventures, LLC which was previously disclosed by the Issuer. /s/Chase C. Leavitt, Attorney-in-fact 2021-07-02